Evidence map›Paper›PMID 28472131›Full record

ArticlePloS one2017

Repeated-dose toxicity of common ragweed on rats.

Tivadar Kiss, Andrea Szabó, Gábor Oszlánczi, Anita Lukács, Zoltán Tímár, László Tiszlavicz, Dezső Csupor

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Effect ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tivadar KissUniversity of Szeged, Faculty of Pharmacy, Department of Pharmacognosy, Szeged, Hungary.
Andrea SzabóUniversity of Szeged, Interdisciplinary Centre for Natural Products, Szeged, Hungary.
Gábor OszláncziUniversity of Szeged, Faculty of Medicine, Department of Public Health, Szeged, Hungary.
Anita LukácsUniversity of Szeged, Faculty of Medicine, Department of Public Health, Szeged, Hungary.
Zoltán TímárSOLVO Biotechnology, Szeged, Hungary.
László TiszlaviczUniversity of Szeged, Faculty of Medicine, Department of Pathology, Szeged, Hungary.
Dezső CsuporUniversity of Szeged, Faculty of Pharmacy, Department of Pharmacognosy, Szeged, Hungary.ORCID http://orcid.org/0000-0002-4088-3333

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ambrosia artemisiifolia L. is an invasive species with highly allergenic pollens. Ragweed originates from North America, but it also occurs and is spreading in Europe, causing seasonal allergic rhinitis for millions of people. Recently, the herb of A. artemisiifolia has gained popularity as medicinal plant and food. The effects of its long-term intake are unknown; there are no toxicological data to support the safe use of this plant. The aim of our study was to assess the repeated dose toxicity of A. artemisiifolia on animals. Ragweed puree was administered in low dose (500 mg/kg b. w.) and high dose (1000 mg/kg b. w.) to male Wistar rats according to 407 OECD Guidelines for the Testing of Chemicals. Clinical symptoms, various blood chemical parameters, body weight and organ weights of the rats were measured. Reduced liver function enzymes (AST, ALT), reduced triglyceride level in the low dose and increased carbamide level in the high dose group were observed. The weight of the liver relative to body weight was significantly reduced in both groups, while the brain weight relative to body weight was significantly elevated in both groups. According to our results, the repeated use of ragweed resulted in toxic effects in rats and these results question the safety of long-term human consumption of common ragweed.

Indexed as

AmbrosiaAllergensAnimalsDose-Response Relationship, ImmunologicMalePollenRatsRats, WistarRhinitis, Allergic, SeasonalAllergens

Identifiers

PMID28472131
PMCPMC5417505

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.